🇺🇸 FDA
Patent

US 12239687

Sustained release formulations using non-aqueous membrane emulsification

granted A61KA61K38/00A61K38/179

Quick answer

US patent 12239687 (Sustained release formulations using non-aqueous membrane emulsification) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/179, A61K47/06, A61K47/34